BRCA1 4153delA founder mutation in Russian ovarian cancer patients
<p>Abstract</p> <p>The BRCA1 4153delA allele is frequently referred to as the Russian founder mutation, as it was initially detected in several cancer families from Moscow. Our earlier studies have demonstrated 1% occurrence of BRCA1 4153delA heterozygosity in familial and/or early...
Main Authors: | Krylova Nadezhda, Lobeiko Oksana S, Sokolenko Anna P, Iyevleva Aglaya G, Rozanov Maxim E, Mitiushkina Natalia V, Gergova Madina M, Porhanova Tatiana V, Urmancheyeva Adel F, Maximov Sergey, Togo Alexandr V, Imyanitov Evgeny N |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-09-01
|
Series: | Hereditary Cancer in Clinical Practice |
Subjects: | |
Online Access: | http://www.hccpjournal.com/content/4/4/193 |
Similar Items
-
Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer
by: Anna P. Sokolenko, et al.
Published: (2023-02-01) -
Genotype-phenotype correlations in patients with breast cancer and BRCA1 mutations (4153delA, 185delAG, 5382insC)
by: Ye. M. Bit-Sava, et al.
Published: (2014-07-01) -
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
by: Salma Wahabi Alzahabi, et al.
Published: (2024-02-01) -
BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel
by: Olfat Ahmad, et al.
Published: (2023-07-01) -
Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12
by: Dolores Gallardo-Rincón, et al.
Published: (2022-06-01)